- In June 2023, Quantum Health formed a partnership with Progyny, Inc. to launch Quantum Health's Comprehensive Care Solutions platform, specifically designed to provide family building and fertility solutions. This collaboration aims to enhance access to fertility services, offering a streamlined approach to care that supports individuals and couples on their journey to parenthood
- In April 2023, Cryoport, Inc. entered into a three-year supply chain agreement with Boston IVF to facilitate the shipment of reproductive materials across the United States. This partnership is intended to ensure the safe and timely transport of critical biological samples, such as eggs, sperm, and embryos, which are essential for fertility treatments
- In October 2022, Maven Clinic, a U.S.-based company specializing in telemedicine and virtual clinic services for women’s and family health, partnered with Indira IVF, an India-based infertility specialty clinic chain. This collaboration aims to extend access to Indira IVF's high-quality clinical care to Maven's members in India, enhancing the support available for family-building needs
- In July 2021, Hamilton Throne Ltd., a global provider of ART research, acquired IVFTECH ApS (IVFtech) and its affiliated company, K4 Technology ApS. This acquisition strengthens IVFtech's commitment to providing laminar flow workstations and large-capacity incubators for assisted reproductive technology (ART), leveraging the resources and expertise of K4 Technology. Together, they aim to enhance the quality and efficiency of ART solutions in the industry
- In May 2021, Virtus Health, a global leader in Assisted Reproductive Services (ARS), announced a strategic partnership with Drop Bio, an Australian biotechnology and digital health firm specializing in chronic inflammation. This collaboration aims to enhance advancements in precision fertility, leveraging both companies' expertise to improve fertility outcomes and tailor treatments to individual patient needs
- In June 2020, Ferring B.V. and Igenomix established a four-year research collaboration focused on developing innovative therapeutic products for the treatment of pregnancy-related conditions. This partnership combines Ferring's expertise in reproductive medicine with Igenomix's cutting-edge genetic analysis capabilities
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Diagnosis, Treatment, and Preservation), Procedure (Assisted Reproductive Technology (ART), In-Vitro Fertilization, Artificial Insemination, Surrogacy, and Others), Services (Donor and Non-donor), End-User (Fertility Clinics, Hospitals, Clinical Research Institutes, and Surgical Centers) – Industry Trends and Forecast to 2031
.
The Global Fertility Services Market size was valued at USD 20.24 USD Billion in 2023.
The Global Fertility Services Market is projected to grow at a CAGR of 7.7% during the forecast period of 2024 to 2031.
The major players operating in the market include , Olympus Corporation , The Cooper Companies , Instituto Bernabeu , Virtus Health , CooperSurgical , Vitrolife , CARE Fertility , INVO Bioscience , Monash IVF , Fertility Focus Limited , Carolinas Fertility Institute , Apollo Hospitals Enterprise , Merck KGaA , LABOTECT GMBH , Medicover ,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
